Thrombosis Research
Volume 126, Issue 2 , Pages 137-143 , August 2010

Microscopic clot fragment evidence of biochemo-mechanical degradation effects in thrombolysis

  • Franci Bajd

      Affiliations

    • Jožef Stefan Institute, Jamova 39, Ljubljana 1000, Slovenia
  • ,
  • Jernej Vidmar

      Affiliations

    • Institute of Physiology, Medical Faculty, University of Ljubljana, Zaloška 4, Ljubljana 1000, Slovenia
  • ,
  • Aleš Blinc

      Affiliations

    • Department of Vascular Diseases, University of Ljubljana Medical Centre, Zaloška 7, Ljubljana 1525, Slovenia
  • ,
  • Igor Serša

      Affiliations

    • Jožef Stefan Institute, Jamova 39, Ljubljana 1000, Slovenia
    • Corresponding Author InformationCorresponding author. Fax: +386 1 477 3696.

Received 11 February 2010 ,Revised 22 April 2010 ,Accepted 23 April 2010.

References 

  1. Stashenko GJ, Hargett CW, Tapson VF. Thrombolytic therapy for venous thromboembolism: current clinical practice. J Hosp Med. 2009;4:313–316
  2. White-Bateman SR, Schumacher HC, Sacco RL, Appelbaum PS. Consent for intravenous thrombolysis in acute stroke: review and future directions. Arch Neurol. 2007;64:785–792
  3. Jenkins PO, Turner MR, Jenkins PF. What is the place of thrombolysis in acute stroke? A review of the literature and a current perspective. Clin Med. 2008;8:253–258
  4. Comerota AJ, Gravett MH. Do randomized trials of thrombolysis versus open revascularization still apply to current management: what has changed?. Semin Vasc Surg. 2009;22:41–46
  5. Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost. 1999;82:259–270
  6. Sersa I, Vidmar J, Grobelnik B, Mikac U, Tratar G, Blinc A. Modelling the effect of laminar axially directed blood flow on the dissolution of non-occlusive blood clots. Phys Med Biol. 2007;52:2969–2985
  7. Wootton DM, Popel AS, Alevriadou BR. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator. Biotechnol Bioeng. 2002;77:405–419
  8. Pleydell CP, David T, Smye SW, Berridge DC. A mathematical model of post-canalization thrombolysis. Phys Med Biol. 2002;47:209–224
  9. Anand S, Diamond SL. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction. Circulation. 1996;94:763–774
  10. Sakharov D, Nagelkerke JF, Rijken DC. Rearangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. J Biol Chem. 1996;26:2133–2138
  11. Grobelnik B, Vidmar J, Tratar G, Blinc A, Sersa I. Flow-induced permeation of non-occlusive blood clots: an MRI study and modelling. Eur Biophys J. 2008;37:1229–1233
  12. Blinc A, Francis CW. Transport processes in fibrinolysis and fibrinolytic therapy. Thromb Haemost. 1996;76:481–491
  13. Šabovič M, Lijnen HR, Keber K, Collen D. Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis. Thromb Haemost. 1990;64:450–454
  14. Blinc A, Keber D, Lahajnar G, Zupancic I, Zorec-Karlovsek M, Demsar F. Magnetic resonance imaging of retracted and nonretracted blood clots during fibrinolysis in vitro. Haemostasis. 1992;22:195–201
  15. Tratar G, Blinc A, Strukelj M, Mikac U, Sersa I. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro. Thromb Haemost. 2004;91:487–496
  16. In:  Colman RC,  Hirsch J,  Marder VJ,  Salzmna E editor. Haemostatis and thrombosis. Basic principles and clinical practice. Philadelphia: JB Lippincitt Co; 1994;
  17. Liu WJLM, Sparks EA, Falvo MR, Hantgan RR, Superfine R, Lord ST, et al. Fibrin fibers have extraordinary extensibility and elasticity. Science. 2006;313:634
  18. Weisel JW. Structure of fibrin: impact on clot stability. J Thromb Haemost. 2007;5(Suppl 1):116–124
  19. Shaw GJ, Dhamija A, Bavani N, Wagner KR, Holland CK. Arrhenius temperature dependence of in vitro tissue plasminogen activator thrombolysis. Phys Med Biol. 2007;52:2953–2967
  20. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78:611–616
  21. Stein PD, Yaekoub AY, Ahsan ST, Matta F, Lala MM, Mirza B, et al. Ankle exercise and venous blood velocity. Thromb Haemost. 2009;101:1100–1103
  22. Tratar G, Blinc A, Podbregar M, Kralj E, Balazic J, Sabovic M, et al. Characterization of pulmonary emboli ex vivo by magnetic resonance imaging and ultrasound. Thromb Res. 2007;120:763–771
  23. Marder VJ, Francis CW. Plasmin degradation of cross-linked fibrin. Ann N Y Acad Sci. 1983;408:397–406
  24. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113:2878–2887

PII: S0049-3848(10)00250-1

doi: 10.1016/j.thromres.2010.04.012

Thrombosis Research
Volume 126, Issue 2 , Pages 137-143 , August 2010